Pilot study of resiniferatoxin administered into the bladder to manage lower urinary tract discomfort in dogs with bladder transitional cell carcinoma


Transitional cell carcinoma is a serious form of cancer that develops in the bladder of dogs. Despite standard therapies, many dogs do not respond well and experience discomfort from this tumor.

The overall goal of this clinical investigation is to determine whether this experimental treatment protocol is more effective and safer than other standard therapies.


Dogs with transitional cell bladder cancer that have clinical signs of lower urinary tract discomfort.

For more information about this study and to inquire about eligibility, please contact Dr. Nicole Liebman at 212-329-8740 or nicole.leibman@amcny.org.

Back to top